SCHEMBL2302785

SCHEMBL2302785

CC(C)(C)c1ccc2n[c]ccc2c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN10A Q9Y5Y9 10/20 0.39
KCNH2 Q12809 1/20 0.39
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
ALDH1A1 P00352 2/20 0.35
HPGD P15428 1/20 0.35
ALOX15 P16050 1/20 0.35
HSD17B10 Q99714 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
METAP2 P50579 1/20 0.34
LRRK2 Q5S007 1/20 0.33
BACE1 P56817 1/20 0.33
MAPT P10636 2/20 0.32
GAA P10253 1/20 0.32
PKM P14618 1/20 0.32
RECQL P46063 1/20 0.32
PLK4 O00444 1/20 0.32
CHEK1 O14757 1/20 0.32
AURKA O14965 1/20 0.32
CHUK O15111 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL407917 0.81 BACE1 (0.51) SCN10AKCNH2METAP2BACE1PKM
SCHEMBL407633 0.75 CYP1A2 (0.55) MEN1KMT2AALDH1A1TDP1BACE1
SCHEMBL10182842 0.73 CYP1A2 (0.59) SCN10AKCNH2MEN1KMT2AALDH1A1
SCHEMBL2303171 0.73 SCN10A (0.38) SCN10AKCNH2MEN1KMT2AALDH1A1
SCHEMBL208188 0.71 F7 (0.38) ALDH1A1HPGDHSD17B10BACE1GAA
SCHEMBL7630593 0.71 KDM4E (0.52) KCNH2MEN1KMT2AALDH1A1HPGD
SCHEMBL315256 0.70 NCF1 (0.51) MEN1KMT2AALDH1A1HPGDSMN1; SMN2
SCHEMBL5748489 0.70 CYP1A2 (0.42) MEN1KMT2AALDH1A1HPGDHSD17B10
SCHEMBL2306818 0.70 SCN10A (0.36) SCN10AKCNH2MEN1KMT2AALDH1A1
SCHEMBL16992698 0.69 SCN9A (0.45) SCN10AKCNH2BACE1CHEK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3044818-A1 ORGANIC ELECTRONIC DEVICE WITH ACTIVE LAYER Heliatek GmbH (DE) 2016-07-20 EP claimed
WO-2015036529-A1 ORGANIC ELECTRONIC DEVICE WITH ACTIVE LAYER HELIATEK GMBH (DE) 2015-03-19 WO claimed
EP-3044818-B1 ORGANIC ELECTRONIC DEVICE WITH ACTIVE LAYER HELIATEK GMBH (DE) 2019-11-13 EP disclosed
EP-3044818-A1 ORGANIC ELECTRONIC DEVICE WITH ACTIVE LAYER Heliatek GmbH (DE) 2016-07-20 EP disclosed
EP-3044818-A1 ORGANIC ELECTRONIC DEVICE WITH ACTIVE LAYER Heliatek GmbH (DE) 2016-07-20 EP disclosed
WO-2015036529-A1 ORGANIC ELECTRONIC DEVICE WITH ACTIVE LAYER HELIATEK GMBH (DE) 2015-03-19 WO disclosed
WO-2015036529-A1 ORGANIC ELECTRONIC DEVICE WITH ACTIVE LAYER HELIATEK GMBH (DE) 2015-03-19 WO disclosed
US-8735577-B2 1,3,5-triazine derivative, process for producing same, and organic electroluminescent element comprising same as constituent component TOSOH CORPORATION (JP) 2014-05-27 US disclosed
EP-2351750-B1 1,3,5-TRIAZINE DERIVATIVE, PROCESS FOR PRODUCING SAME, AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME AS CONSTITUENT TOSOH CORP (JP) 2014-03-12 EP disclosed
US-20110190494-A1 1,3,5-TRIAZINE DERIVATIVE, PROCESS FOR PRODUCING SAME, AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME AS CONSTITUENT COMPONENT TOSOH CORPORATION (JP) 2011-08-04 US disclosed
EP-2351750-A1 1,3,5-TRIAZINE DERIVATIVE, PROCESS FOR PRODUCING SAME, AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME AS CONSTITUENT COMPONENT Tosoh Corporation (JP) 2011-08-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110190494-A1 1,3,5-TRIAZINE DERIVATIVE, PROCESS FOR PRODUCING SAME, AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME AS CONSTITUENT COMPONENT ASH2L, SETDB1, KAT5 SCN10A 2430/4885KCNH2 93/4885MEN1 2148/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.